Every material Form 8-K UnitedHealth filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
UnitedHealth Group named Scott Gottlieb, M.D., a former FDA commissioner, as an independent director effective immediately, as announced November 18, 2025. He has not yet been assigned to any board committees. The filing describes standard director compensation and indemnification arrangements, and no financial results or guidance were reported.
Scott Gottlieb, M.D. appointed independent director, effective immediately, announced November 18, 2025
Gottlieb has not yet been appointed to any board committees
He served as FDA commissioner from 2017 to 2019 and also serves as a director of Pfizer, Tempus AI and Illumina
Compensation follows the company's standard non-employee director program; he is entering the standard indemnification agreement
UnitedHealth Group said senior leaders will take part in an interview-format discussion at the UBS Global Healthcare Conference 2025 on Monday, November 10, 2025, starting at 8:45 a.m. Eastern Time. The discussion will cover strategy, market positions, recent results and expectations for its end markets, and a live audio webcast will be posted on the company's Investor Relations page. The filing contains no new financial figures, so it adds no new earnings or guidance information for shareholders.
Presentation at UBS Global Healthcare Conference 2025 on Monday, November 10, 2025, beginning 8:45 a.m. Eastern Time
Topics include strategy, market positions, recent results and expectations for end markets
Live audio webcast available through the Investor Relations page at www.unitedhealthgroup.com
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every UnitedHealth filing is on SEC EDGAR ↗. 8-K briefs of other companies →